This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Peptidream Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Masataka Umitsu: Innovator in Peptide Technology
Introduction
Masataka Umitsu is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of peptide technology, particularly in relation to growth hormone receptors. His innovative work has led to the development of a unique peptide that has potential applications in various therapeutic areas.
Latest Patents
Masataka Umitsu holds a patent for a GhR-binding peptide and composition comprising the same. This technology relates to peptides that bind to the growth hormone receptor (GhR) and includes peptides that exhibit antagonistic activity. The implications of this patent are vast, as it opens new avenues for research and development in hormone-related therapies.
Career Highlights
Umitsu is associated with Peptidream Inc., a company known for its cutting-edge research in peptide-based therapeutics. His work at Peptidream has positioned him as a key player in the biotechnology sector, where he continues to push the boundaries of what is possible with peptide technology.
Collaborations
One of his notable collaborators is Tatsuya Tomiyama. Together, they have worked on advancing the understanding and application of peptides in medical science.
Conclusion
Masataka Umitsu's contributions to peptide technology, particularly through his patent on GhR-binding peptides, highlight his role as an innovator in the field. His work continues to inspire advancements in therapeutic applications, showcasing the importance of innovation in biotechnology.